Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Choo Chee Kong

Over the trailing 90 days, Choo Chee Kong (Director at CytoMed Therapeutics Ltd) traded $429K of stock (net selling $171K) in GDTC, per 3 SEC Form 4 transactions.

Role
Director
Companies
GDTC
Window
Trailing 90 days · 3 transactions · CIK 1970632
Net activity
−$171K ($129K bought · $300K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
GDTCCytoMed Therapeutics Ltd3$129K$300K−$171K

Transactions (3)

DateSymbolTypeSharesValueDescription
2026-07-20GDTCSell100.0K$150KOpen market or private purchase
2026-07-14GDTCSell100.0K$150KOpen market or private purchase
2026-05-13GDTCBuy112.0K$129KOpen market or private purchase

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Choo's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free